Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/614   
Active ingredient: Mifepristone
Indication: Treatment of hypercortisolism (Cushing's syndrome) of endogenous origin
Sponsor: EXELGYN
216 boulevard Saint-Germain, 75007 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/03/2009 Orphan designation EMEA/OD/086/08 (2009)1527 of 27/02/2009